UTHR
United Therapeutics Corp

2,434
Mkt Cap
$33.82B
Volume
297,163.00
52W High
$519.99
52W Low
$266.98
PE Ratio
18.40
UTHR Fundamentals
Price
$486.86
Prev Close
$478.93
Open
$483.81
50D MA
$486.64
Beta
0.43
Avg. Volume
353,460.35
EPS (Annual)
$24.64
P/B
3.16
Rev/Employee
$2.2M
Loading...
Loading...
News
all
press releases
United Therapeutics Corporation $UTHR Shares Sold by Ashton Thomas Private Wealth LLC
Ashton Thomas Private Wealth LLC cut its holdings in shares of United Therapeutics Corporation (NASDAQ:UTHR - Free Report) by 79.7% during the third quarter, according to the company in its most...
MarketBeat·13h ago
News Placeholder
More News
News Placeholder
Allianz Asset Management GmbH Trims Stake in United Therapeutics Corporation $UTHR
Allianz Asset Management GmbH lowered its position in United Therapeutics Corporation (NASDAQ:UTHR - Free Report) by 29.7% in the 3rd quarter, according to the company in its most recent disclosure...
MarketBeat·2d ago
News Placeholder
Merck's Subdued 2026 Outlook: What it Means After Q4 Results?
MRK posts conservative 2026 sales and EPS outlook, given acquisition charges. Keytruda, Animal Health and new drug launches are expected to drive 2026 growth.
Zacks·2d ago
News Placeholder
United Therapeutics (NASDAQ:UTHR) EVP Paul Mahon Sells 8,300 Shares
United Therapeutics Corporation (NASDAQ:UTHR - Get Free Report) EVP Paul Mahon sold 8,300 shares of the firm's stock in a transaction that occurred on Thursday, February 5th. The shares were sold at...
MarketBeat·2d ago
News Placeholder
BI Asset Management Fondsmaeglerselskab A S Cuts Stock Holdings in United Therapeutics Corporation $UTHR
BI Asset Management Fondsmaeglerselskab A S lessened its stake in United Therapeutics Corporation (NASDAQ:UTHR - Free Report) by 28.4% during the third quarter, according to the company in its most...
MarketBeat·2d ago
News Placeholder
Paul Mahon Sells 8,300 Shares of United Therapeutics (NASDAQ:UTHR) Stock
United Therapeutics Corporation (NASDAQ:UTHR - Get Free Report) EVP Paul Mahon sold 8,300 shares of United Therapeutics stock in a transaction dated Thursday, February 5th. The shares were sold at an...
MarketBeat·3d ago
News Placeholder
Biotech Stocks To Add to Your Watchlist - February 5th
Danaher, argenex, Vertex Pharmaceuticals, Moderna, Recursion Pharmaceuticals, United Therapeutics, and Medpace are the seven Biotech stocks to watch today, according to MarketBeat's stock screener...
MarketBeat·3d ago
News Placeholder
Principal Financial Group Inc. Sells 5,583 Shares of United Therapeutics Corporation $UTHR
Principal Financial Group Inc. decreased its stake in shares of United Therapeutics Corporation (NASDAQ:UTHR - Free Report) by 5.0% during the third quarter, according to the company in its most...
MarketBeat·4d ago
News Placeholder
United Therapeutics (NASDAQ:UTHR) Director Jan Malcolm Sells 50 Shares
United Therapeutics Corporation (NASDAQ:UTHR - Get Free Report) Director Jan Malcolm sold 50 shares of the stock in a transaction that occurred on Tuesday, February 3rd. The stock was sold at an...
MarketBeat·5d ago
News Placeholder
Mediolanum International Funds Ltd Sells 4,275 Shares of United Therapeutics Corporation $UTHR
Mediolanum International Funds Ltd cut its holdings in shares of United Therapeutics Corporation (NASDAQ:UTHR - Free Report) by 23.2% in the third quarter, according to the company in its most recent...
MarketBeat·5d ago
<
1
2
...
>

Latest UTHR News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.